Mandate

Vinge has advised Europart in connection with its acquisition of Trailereffekter and LVD Lastvagnsdelar, two distributors of parts for heavy vehicles, from Axel Johnson International.

February 02, 2016

Vinge has advised Europart, a German provider of commercial vehicle spare parts that was acquired by private equity firm Triton in 2011, in connection with its acquisition of Trailereffekter and LVD Lastvagnsdelar, two distributors of parts for heavy vehicles, from Axel Johnson International.

The strategic rationale behind the transaction is Europart’s interest in growing its market presence in Sweden where the company currently has six branch offices. Europart has annual sales of EUR 412m and 1,600 employees. Trailereffekter and LVD have 16 branch offices throughout Sweden, annual revenue of SEK 264m (about EUR 28.4m as of 1 February 2016) and 93 employees.

The agreement on the acquisition of Trailereffekter AB and LVD Lastvagnsdelar Svenska AB by Europart i Sverige AB (a subsidiary of Europart Holding GmbH) was signed January 29. The transaction is expected to be concluded during March, 2016, pending clearance from competition authorities in Sweden.

Vinge’s team consisted of, among others, partner Christina Kokko and Johan Göthberg together with associate Louise Nordkvist (M&A), partner Marcus Glader and associates Helena Höök and Johanna Bjurling (competition law), and associates Anna Lonergan (real property), Karin Isacson (employment), Mathilda Persson (IT) and Tomas Forsgren (IP).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025